Skip to main content

HESA Committee Meeting

Notices of Meeting include information about the subject matter to be examined by the committee and date, time and place of the meeting, as well as a list of any witnesses scheduled to appear. The Evidence is the edited and revised transcript of what is said before a committee. The Minutes of Proceedings are the official record of the business conducted by the committee at a sitting.

For an advanced search, use Publication Search tool.

If you have any questions or comments regarding the accessibility of this publication, please contact us at accessible@parl.gc.ca.

Previous day publication Next day publication

Minutes of Proceedings

44th Parliament, 1st Session
Meeting 2
Friday, January 14, 2022, 1:01 p.m. to 1:43 p.m.
Televised
Presiding
Sean Casey (Liberal)

Library of Parliament
• Sonya Norris, Analyst
Pursuant to Standing Order 106(4), the committee commenced consideration of the request by four members of the committee to undertake a study of recent COVID-19 developments.

Motion

Luc Berthold moved, — That the Committee hold a meeting to invite the Minister of Health, the Deputy Minister of Health Canada, the Deputy Minister of Public Services and Procurement, the President of the Public Health Agency of Canada, the Chief Public Health Officer of Canada, the Vice President of Logistics and Operations for the Public Health Agency of Canada, and the head of the National Advisory Committee on Immunization, to discuss recent COVID-19 developments including, but not limited to,

• Status of support for the provinces to address surge healthcare resources

• Current advice regarding quarantine length

• Availability of mRNA vaccine boosters, including procurement strategies for potential variant specific vaccines

• Availability of rapid tests and status of public education on the same

• Status of review and procurements of promising new therapeutics such as Pfizer’s Paxlovid

• Access to n95 masks and other PPE

• Status of domestic manufacturing capacity for mRNA vaccines

That the meeting be at least three hours in length, that the relevant departments for which officials have been requested be invited and asked to prioritize their attendance but that the meeting not be delayed if they are unable to prioritize attendance at the meeting, that the total time allotted for opening statements be limited to 5 minutes by witnesses for no more than 20 minutes total to ensure adequate time for questions to be posed by committee members, and that this meeting be held on or before the end of day on Wednesday, January 19, 2022.

Debate arose thereon.

Amendment

It was agreed, — That the motion be amended by adding the words “and territories” after the word “provinces”.

After debate, the question was put on the motion, as amended, and it was agreed to.

The motion, as amended, read as follows:

That the Committee hold a meeting to invite the Minister of Health, the Deputy Minister of Health Canada, the Deputy Minister of Public Services and Procurement, the President of the Public Health Agency of Canada, the Chief Public Health Officer of Canada, the Vice President of Logistics and Operations for the Public Health Agency of Canada, and the head of the National Advisory Committee on Immunization, to discuss recent COVID-19 developments including, but not limited to,

• Status of support for the provinces and territories to address surge healthcare resources

• Current advice regarding quarantine length

• Availability of mRNA vaccine boosters, including procurement strategies for potential variant specific vaccines

• Availability of rapid tests and status of public education on the same

• Status of review and procurements of promising new therapeutics such as Pfizer’s Paxlovid • Access to n95 masks and other PPE

• Status of domestic manufacturing capacity for mRNA vaccines

That the meeting be at least three hours in length, that the relevant departments for which officials have been requested be invited and asked to prioritize their attendance but that the meeting not be delayed if they are unable to prioritize attendance at the meeting, that the total time allotted for opening statements be limited to 5 minutes by witnesses for no more than 20 minutes total to ensure adequate time for questions to be posed by committee members, and that this meeting be held on or before the end of day on Wednesday, January 19, 2022.

At 1:43 p.m., the committee adjourned to the call of the Chair.



Michael MacPherson
Committee Clerk